Pomerantz Appointed Co-Lead Counsel in Odonate Therapeutics Securities Litigation

On December 14, 2020, U.S District Judge Marilyn L. Huff of the Southern District of California appointed Pomerantz LLP as Co-Lead Counsel on behalf of Lead Plaintiff Kevin Kendall in Kendall v. Odonate Therapeutics, Inc., 20-cv-1828 (S.D. Cal.), a securities litigation being pursued on behalf of a class of defrauded investors concerning allegations that Odonate Therapeutics, Inc. had misrepresented the safety and commercial viability of one of its cancer treatments.